Einzeltreffer — DigiBib

Objective: To review the research progress of different cell seeding densities and cell ratios in cartilage tissue engineering.

Methods: The literature about tissue engineered cartilage constructed with three-dimensional scaffold was extensively reviewed, and the seeding densities and ratios of most commonly used seed cells were summarized.

Results: Articular chondrocytes (ACHs) and bone marrow mesenchymal stem cells (BMSCs) are the most commonly used seed cells, and they can induce hyaline cartilage formation in vitro and in vivo . Cell seeding density and cell ratio both play important roles in cartilage formation. Tissue engineered cartilage with good quality can be produced when the cell seeding density of ACHs or BMSCs reaches or exceeds that in normal articular cartilage. Under the same culture conditions, the ability of pure BMSCs to build hyaline cartilage is weeker than that of pure ACHs or co-culture of both.

Conclusion: Due to the effect of scaffold materials, growth factors, and cell passages, optimal cell seeding density and cell ratio need further study.

Titel:	[Research progress of different cell seeding densities and cell ratios in cartilage tissue engineering].
Autor/in / Beteiligte Person:	Xie, H ; Zhou, W ; Bai, B ; Zhang, S
Zeitschrift:	Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, Jg. 36 (2022-04-15), Heft 4, S. 470-478
Veröffentlichung:	Chengdu Shi : Hua xi yi ke da xue Fu shu di 1 yi yuan ; <i>Original Publication</i>: Chengdu Shi : Hua xi yi ke da xue Fu shu di 1 yi yuan,, 2022
Medientyp:	academicJournal
ISSN:	1002-1892 (print)
DOI:	10.7507/1002-1892.202110091
Schlagwort:	Bone Marrow Cells Cells, Cultured Chondrocytes metabolism Chondrogenesis Tissue Scaffolds Cartilage, Articular Tissue Engineering methods
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: Chinese Publication Type: Journal Article; Review Language: Chinese [Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi] 2022 Apr 15; Vol. 36 (4), pp. 470-478. MeSH Terms: Cartilage, Articular* ; Tissue Engineering* / methods ; Bone Marrow Cells ; Cells, Cultured ; Chondrocytes / metabolism ; Chondrogenesis ; Tissue Scaffolds References: Anat Rec A Discov Mol Cell Evol Biol. 2004 May;278(1):428-36. (PMID: 15103737) ; Tissue Eng Part A. 2018 Nov;24(21-22):1693-1703. (PMID: 29792383) ; Osteoarthritis Cartilage. 2013 Apr;21(4):599-603. (PMID: 23376013) ; Biotechnol Prog. 2008 Mar-Apr;24(2):452-7. (PMID: 18197674) ; Arthroscopy. 2016 Mar;32(3):495-505. (PMID: 26432430) ; J Bone Joint Surg Am. 2013 Jun 5;95(11):1045-54. (PMID: 23780543) ; Tissue Eng Part B Rev. 2017 Dec;23(6):515-528. (PMID: 28490258) ; Tissue Eng Part A. 2011 Apr;17(7-8):1111-22. (PMID: 21142626) ; Biomaterials. 2008 Aug;29(22):3201-12. (PMID: 18462789) ; Biomed Mater. 2015 Jan 29;10(1):015018. (PMID: 25634427) ; Osteoarthritis Cartilage. 2015 Oct;23(10):1806-16. (PMID: 26050867) ; BMC Musculoskelet Disord. 2016 Jul 20;17:301. (PMID: 27439428) ; J Orthop Surg Res. 2020 Mar 30;15(1):120. (PMID: 32228637) ; Tissue Eng Part B Rev. 2011 Aug;17(4):213-27. (PMID: 21406046) ; Am J Sports Med. 1998 Mar-Apr;26(2):309-24. (PMID: 9548130) ; Artif Organs. 2003 Mar;27(3):249-55. (PMID: 12662211) ; Ann Biomed Eng. 2002 Sep;30(8):1046-56. (PMID: 12449765) ; N Engl J Med. 1994 Oct 6;331(14):889-95. (PMID: 8078550) ; Tissue Eng. 2005 Sep-Oct;11(9-10):1421-8. (PMID: 16259597) ; Acta Biomater. 2005 Nov;1(6):625-33. (PMID: 16701843) ; Osteoarthritis Cartilage. 2013 Dec;21(12):1904-12. (PMID: 24455780) ; In Vitro Cell Dev Biol Anim. 2002 Sep;38(8):457-66. (PMID: 12605540) ; Am J Sports Med. 2019 Feb;47(2):347-354. (PMID: 30545242) ; J Biomech. 2016 Jun 14;49(9):1909-1917. (PMID: 27198889) ; J Tissue Eng Regen Med. 2015 Dec;9(12):1394-403. (PMID: 23225781) ; Biomaterials. 2012 Sep;33(27):6362-9. (PMID: 22695067) ; Biochem Pharmacol. 2019 Jul;165:49-65. (PMID: 30853397) ; J Biomed Mater Res A. 2010 Dec 1;95(3):924-31. (PMID: 20845491) ; Biomaterials. 2006 Sep;27(25):4434-42. (PMID: 16677707) ; J Biomed Mater Res A. 2009 Dec;91(3):910-8. (PMID: 19097150) ; Tissue Eng Part A. 2009 Jul;15(7):1729-37. (PMID: 19115827) ; J Biomed Mater Res. 2000 Nov;52(2):246-55. (PMID: 10951362) ; Tissue Eng Part B Rev. 2019 Aug;25(4):357-373. (PMID: 30913997) ; Bone. 2009 Jul;45(1):42-51. (PMID: 18708174) ; Am J Transl Res. 2015 Feb 15;7(2):194-208. (PMID: 25901191) ; Sports Health. 2009 Nov;1(6):461-8. (PMID: 23015907) ; J Tissue Eng Regen Med. 2016 Oct;10(10):E485-E496. (PMID: 24668937) ; J Mater Sci Mater Med. 2007 Feb;18(2):273-81. (PMID: 17323158) ; Biomaterials. 2020 Mar;235:119821. (PMID: 32006743) ; Tissue Eng Part A. 2012 Aug;18(15-16):1542-51. (PMID: 22429306) ; Tissue Eng Part B Rev. 2014 Dec;20(6):596-608. (PMID: 24749845) ; Acta Orthop Belg. 2010 Oct;76(5):669-74. (PMID: 21138224) ; Biotechnol Bioeng. 2012 Sep;109(9):2357-68. (PMID: 22508498) ; J Tissue Eng Regen Med. 2017 Jun;11(6):1710-1722. (PMID: 26178016) ; Tissue Eng. 2006 Jun;12(6):1675-85. (PMID: 16846362) ; J Mater Chem B. 2017 Jul 14;5(26):5109-5119. (PMID: 32264096) ; Tissue Eng Part C Methods. 2014 Jan;20(1):52-63. (PMID: 23672760) ; Nat Rev Rheumatol. 2019 Sep;15(9):550-570. (PMID: 31296933) ; Biotechnol Bioeng. 2006 Apr 20;93(6):1152-63. (PMID: 16470881) ; Osteoarthritis Cartilage. 2012 Oct;20(10):1170-8. (PMID: 22796508) ; Biotechnol Prog. 2003 Mar-Apr;19(2):510-21. (PMID: 12675595) ; Tissue Eng Part A. 2011 May;17(9-10):1425-36. (PMID: 21247341) ; Acta Biomater. 2014 May;10(5):1919-29. (PMID: 24418436) ; Stem Cells Transl Med. 2017 Apr;6(4):1295-1303. (PMID: 28177194) ; J Biomed Mater Res B Appl Biomater. 2019 Nov;107(8):2649-2657. (PMID: 30860678) ; Biomaterials. 2010 Mar;31(9):2470-6. (PMID: 20022630) ; J Biomed Mater Res A. 2012 Oct;100(10):2717-25. (PMID: 22623365) ; Tissue Eng Part C Methods. 2014 Apr;20(4):340-57. (PMID: 24007559) ; Tissue Eng Part A. 2011 Feb;17(3-4):371-80. (PMID: 20799905) ; JAMA. 2017 May 16;317(19):1967-1975. (PMID: 28510679) ; PLoS One. 2014 Mar 13;9(3):e91662. (PMID: 24626259) ; Hum Gene Ther. 2010 Oct;21(10):1226-38. (PMID: 20804388) ; Acta Biomater. 2017 Aug;58:302-311. (PMID: 28611002) Contributed Indexing: Keywords: Cartilage tissue engineering; articular chondrocytes; bone marrow mesenchymal stem cells; cell ratio; co-culture; seeding density ; Local Abstract: [Publisher, Chinese] 综述软骨组织工程中种子细胞接种密度和比例的研究进展。. [Publisher, Chinese] 广泛查阅三维结构中构建组织工程软骨的相关文献，对最常用的种子细胞接种密度与比例进行综述。. [Publisher, Chinese] 关节软骨细胞（articular chondrocytes，ACHs）和BMSCs是软骨组织工程中最常用的种子细胞，体内、外实验显示两种细胞均具有一定形成透明软骨的能力。而种子细胞的接种密度和比例对最终形成的组织工程软骨质量有重要影响。ACHs或BMSCs细胞接种密度接近或高于正常关节软骨中的细胞密度时，可构建出质量较好的组织工程软骨。在相同培养条件下，BMSCs在单独应用时形成透明软骨的能力不如ACHs或两者共培养。. [Publisher, Chinese] 受支架材料、生长因子、细胞代次等因素影响，软骨组织工程中最优的细胞接种密度与比例仍需进一步研究。. Entry Date(s): Date Created: 20220415 Date Completed: 20220418 Latest Revision: 20220716 Update Code: 20240513 PubMed Central ID: PMC9011064

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

[Research progress of different cell seeding densities and cell ratios in cartilage tissue engineering].